Justin Timberlake reveals Lyme disease battle during tour, highlighting challenges and support from loved ones.
Xylem's strong Q2 2025 results, with raised full-year guidance, drive shares to surge as the company's operational improvements and resilient demand fuel growth.
Shell's profits fall due to lower oil and gas prices, outages, and economic uncertainty, but the company maintains its buyback program and cost-cutting efforts.
Justin Timberlake reveals Lyme disease battle during tour, highlighting challenges and support from loved ones.
Xylem's strong Q2 2025 results, with raised full-year guidance, drive shares to surge as the company's operational improvements and resilient demand fuel growth.
Shell's profits fall due to lower oil and gas prices, outages, and economic uncertainty, but the company maintains its buyback program and cost-cutting efforts.
